KSA-Based Madeed Secures US$925,000 To Scale Its AI-Driven Preventive Healthcare Platform Across The GCC
Madeed founder Adam Bataineh told Inc. Arabia that he launched his enterprise to "help people reach their best years of health and stay there for as long as possible."
Following a US$400,000 pre-seed round in January 2026, Madeed, a Saudi Arabia-based platform focused on preventative personalized healthcare, has raised additional funds that brings the total investment it has secured to $925,000.
The new capital came from investors like SEEDRA Ventures, a Riyadh-based venture capital (VC) firm, Unity Investment Partners, a KSA-based private equity firm, and Seen Growth, a KSA-based investment company. Its earlier round included participation from Vision Ventures, a sector-agnostic KSA-based VC firm, and a group of individual investors including Mashhoor Aldubayan, angel investor and General Manager of Mashhoor, a Riyadh-based consulting company; Mazen Aldarrab, founder and CEO of Zid, an e-commerce enablement platform based in Riyadh, and Abdulla Nadeem Elyas, a co-founder of the UAE-born super app Careem.
Founded by physician and entrepreneur Adam Bataineh in 2025 in Riyadh, Madeed is developing a preventive healthcare platform that leverages advanced biomarkers and laboratory testing to identify disease risks at an early stage. Madeed is not Bataineh’s first foray into longevity and healthtech; he had previously co-founded the US-based longevity coaching platform Span Health, which was acquired by the American sleep technology company Sleep Eight in 2022.
In an interview with Inc. Arabia, Bataineh shared that Madeed was built to bring a personalized and prevention-driven approach to healthcare in the MENA. “We launched Madeed in Saudi Arabia to help people reach their best years of health and stay there for as long as possible,” he said. “Our mission is not only to help people live longer, though, it is to help them stay energetic, metabolically healthy, mentally sharp, and physically capable for more of their lives.”
According to Bataineh, Madeed shifts healthcare toward early prevention and longevity, supported by artificial intelligence (AI)-native tools that streamline access and connect patients directly to diagnostics. “What really makes us different is that we are building around the concept of ‘peak health’ rather than just disease avoidance," Bataineh said. "Traditional lab ranges are designed to identify illnesses. We’re more interested in identifying early drift, the subtle metabolic, inflammatory, hormonal, and nutritional changes that gradually move people away from optimal health years before disease develops."
As such, Madeed targets what Bataineh believes is an unmet need for personalized preventive healthcare solutions in the market, with that gap—coupled with the company’s early traction—also driving investors’ confidence. “I think our investors also see that the GCC is uniquely positioned for this shift in healthcare," he noted. "You have a young, digitally native population with rising health awareness, and governments investing heavily in healthcare transformation. But despite that, the region still lacks deeply personalized preventive health platforms built specifically for its population. The strong traction, even with very early versions of our product, proved this to be especially true."
Having set up shop in Saudi Arabia, Madeed is now set to expand its clinical and laboratory partnerships in the Kingdom and wider GCC region, driven by growing demand for consumer-facing preventive health solutions. “The region is shifting to data-driven healthcare," Bataineh noted. "People are already using AI to analyze their health data. Even in the earliest stages of Madeed, we’ve seen strong user interest in a preventive, personalized approach that is highly trusted. This signals clear market readiness and growing demand for more proactive ways to manage health and well-being. People now have access to tools that previously existed only within medical institutions or elite performance centers. They can track advanced biomarkers and get a deep analysis of all their data. They are becoming far more informed, curious, and proactive about their health. What’s changing is that healthcare is becoming consumer-driven, and we are giving the consumer the tools they need to reach better health."
As demand for preventive health thus grows across the region, it is doing so against a backdrop of wider uncertainty driven by geopolitical tensions. But for Bataineh, that only reinforces the need for founders to stay focused on what they can control—especially in healthcare, where complexity is part of the business itself. “I try to focus on what I can change and not get distracted by macro uncertainty," he said. "It’s a distraction. In healthcare specifically, founders can become overwhelmed by regulations, difficult-to-navigate pathways, and honestly, a lot of operationally boring work. But I actually think that’s precisely where the opportunity lies. The barrier to creating another app is collapsing rapidly. What is harder to build is companies that operate in the real world, navigate complexity, earn trust, and integrate deeply into people’s lives. Healthcare is one of those spaces, and the MENA is definitely in need for this.”
Pictured in the lead image is Adam Bataineh, founder and CEO of Madeed. Courtesy of Madeed.
